(Q24202489)

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Regular vs prn nebulized treatment in wheeze preschool children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Daily or intermittent budesonide in preschool children with recurrent wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The effect of inhaled albuterol in moderate to severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Swimming and persons with mild persistant asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Maintenance and symptom relief with budesonide plus formoterol reduced severe asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The development and establishment of a care map in children with asthma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Clinical equivalence trial on budesonide delivered either by the Novolizer multidose dry powder inhaler or the Turbuhaler in asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Impact of a novel nutritional formula on asthma control and biomarkers of allergic airway inflammation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The use of twice daily nedocromil sodium in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effectiveness and safety of salmeterol in nonspecialist practice settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Celiprolol--review of airways studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A new index of prognostic severity for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Fluticasone propionate compared with theophylline for mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Tolerance to the protective effect of salmeterol in mild untreated asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Single centre open study to compare patient recording of PRN salbutamol use on a daily diary card with actual use as recorded by the MDI compliance monitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Clinical effects of a Long-term Educational Program for children with asthma - Aironet. A 1-yr randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A one-year trial of triamcinolone acetonide aerosol in severe steroid-dependent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Continuous and intermittent salbutamol tablet administration in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Improvements with tiotropium in COPD patients with concomitant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Minimal tolerance to the bronchoprotective effect of inhaled salmeterol/fluticasone combination on allergene challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Randomized controlled trial of fluticasone in preschool children with intermittent wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Efficacy of IV theophylline in children with severe status asthmaticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Randomised trial comparing as-needed versus regular treatment with formoterol in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effect of disease duration on dose-response of inhaled budesonide in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Clinical comparability of ventolin formulated with hydrofluoroalkane or conventional chlorofluorocarbon propellants in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Double blind randomised controlled trial of two different breathing techniques in the management of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Betamethasone 17-valerate in childhood asthma. A double-blind crossover trial in children not taking other corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Efficacy of calcium channel blockers as maintenance therapy for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Haemodynamic responses to salbutamol and isometric exercise are altered in young adults with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Asthma symptoms, morbidity, and antiinflammatory use in inner-city children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The relationship among inspiratory muscle strength, the perception of dyspnea and inhaled beta2-agonist use in patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

A one-week dose-ranging study of inhaled salmeterol in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Impact of steroids on recovery after uvulopalatopharyngoplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Predictors of Symptoms Are Different From Predictors of Severe Exacerbations From Asthma in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Preemptive use of high-dose fluticasone for virus-induced wheezing in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Adherence rate to inhaled corticosteroids and their impact on asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Inhaled steroids for episodic viral wheeze of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

The Childhood Asthma Management Program (CAMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

The effect of sustained-release aminophylline on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Long term treatment of severe asthma with subcutaneous terbutaline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

A clinical and immunologic study of colchicine in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Intermittent or daily montelukast versus placebo for episodic asthma in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Socioeconomic status and medication prescription patterns in pediatric asthma in Canada

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Short-acting inhaled beta-agonists: to be taken regularly or as needed?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Regular vs as-needed inhaled salbutamol in asthma control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Airway inflammatory response to ozone in subjects with different asthma severity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Need for theophylline in severe steroid-requiring asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Efficacy of salmeterol in the treatment of childhood asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Six-year follow-up of an intervention to improve the management of preschool children with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or non-steroidal conventional asthma therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Intermittent and continuous salbutamol rotacaps inhalation in asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

No Effect of Inhaled Budesonide on the Response to Inhaled Ozone in Normal Subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

A clinical index to define risk of asthma in young children with recurrent wheezing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Acute response to 3.0 ppm formaldehyde in exercising healthy nonsmokers and asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals--a lesser benefit in females

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Multi-centre clinical trial of nedocromil sodium in reversible obstructive airways disease in adults: a general practitioner collaborative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Controlled trial of two formulations of cromolyn sodium in the treatment of asthmatic patients > or = 12 years of age. Intal Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009611.PUB2

7 January 2021